- Home
- SMHI vs NYXH Comparison
SMHI vs NYXH Comparison
Compare SMHI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- NYXH
- Stock Information
- Founded
- SMHI 1989
- NYXH 2009
- Country
- SMHI United States
- NYXH Belgium
- Employees
- SMHI N/A
- NYXH N/A
- Industry
- SMHI Marine Transportation
- NYXH Medical/Dental Instruments
- Sector
- SMHI Consumer Discretionary
- NYXH Health Care
- Exchange
- SMHI Nasdaq
- NYXH Nasdaq
- Market Cap
- SMHI 186.4M
- NYXH 188.1M
- IPO Year
- SMHI N/A
- NYXH 2021
- Fundamental
- Price
- SMHI $6.98
- NYXH $4.60
- Analyst Decision
- SMHI
- NYXH Strong Buy
- Analyst Count
- SMHI 0
- NYXH 3
- Target Price
- SMHI N/A
- NYXH $12.67
- AVG Volume (30 Days)
- SMHI 113.5K
- NYXH 47.3K
- Earning Date
- SMHI 10-29-2025
- NYXH 11-13-2025
- Dividend Yield
- SMHI N/A
- NYXH N/A
- EPS Growth
- SMHI N/A
- NYXH N/A
- EPS
- SMHI N/A
- NYXH N/A
- Revenue
- SMHI $245,311,000.00
- NYXH $6,616,215.00
- Revenue This Year
- SMHI N/A
- NYXH $85.62
- Revenue Next Year
- SMHI $8.81
- NYXH $320.09
- P/E Ratio
- SMHI N/A
- NYXH N/A
- Revenue Growth
- SMHI N/A
- NYXH 10.96
- 52 Week Low
- SMHI $3.63
- NYXH $4.35
- 52 Week High
- SMHI $7.88
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- SMHI 51.51
- NYXH 39.26
- Support Level
- SMHI $6.70
- NYXH $4.45
- Resistance Level
- SMHI $7.27
- NYXH $4.76
- Average True Range (ATR)
- SMHI 0.47
- NYXH 0.30
- MACD
- SMHI -0.06
- NYXH -0.04
- Stochastic Oscillator
- SMHI 37.84
- NYXH 13.25
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.